Skip to main content

Table 1 Characteristics of the treatment groups

From: Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery?

 

Radiosurgery alone N patients (%)

Radiosurgery + WBRT N patients (%)

P -value

Radiosurgery dose

   

  <20 Gy (n = 23)

10 (33)

13 (46)

 

  ≥20 Gy (n = 35)

20 (67)

15 (54)

0.63

Age

   

  ≤59 years (n = 34)

17 (57)

17 (61)

 

  ≥60 years (n = 24)

13 (43)

11 (39)

0.94

ECOG performance score

   

  0-1 (n = 40)

20 (67)

20 (71)

 

  2 (n = 18)

10 (33)

8 (29)

0.93

Number of cerebral metastases

   

  1 (n = 46)

25 (83)

21 (75)

 

  2-3 (n = 12)

5 (17)

7 (25)

0.84

Maximum diameter of all brain metastases

   

  ≤10 mm (n = 28)

15 (50)

13 (46)

 

  ≥11 mm (n = 30)

15 (50)

15 (54)

0.95

Site of brain metastases

   

  Supratentorial (n = 39)

20 (67)

19 (68)

 

  Infratentorial ± supratentorial (n = 19)

10 (33)

9 (32)

0.98

Extra-cranial metastases

   

  No (n = 24)

11 (37)

13 (46)

 

  Yes (n = 34)

19 (63)

15 (54)

0.75

Time from breast cancer diagnosis to radiotherapy

   

  ≤48 months (n = 30)

15 (50)

15 (54)

 

  ≥49 months (n = 28)

15 (50)

13 (46)

0.95

  1. P-values were obtained with the Chi-square test.